Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 11Colonic Neoplasms 7Breast Neoplasms 7Lung Neoplasms 6Brain Neoplasms 4Urinary Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Respiratory Aspiration 2Rectal Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Neoplasm Metastasis 2Melanoma 2Uterine Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Recurrence 1Quality of Recovery 1Postoperative Cognitive Complications 1Pain, Postoperative 1Neurofibromatoses 1Myofibroma 1Liver Neoplasms 1Liver Functions Tests 1Intraoral Tumor 1Inflammation 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Melanoma × Sevoflurane × Clear all
NCT04074460 2022-06-09

VAPOR-C

Peter MacCallum Cancer Centre, Australia

Phase 4 Completed
169 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT01588847 2014-12-11

Anesthesia and Cancer Recurrence im Malignant Melanoma

University Hospital Muenster

Phase NA Unknown
230 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡